mevalonic acid has been researched along with Primary Peritonitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abebayehu, D; Barnstein, BO; Burchett, JR; Caslin, HL; Dailey, JM; Gomez, G; Haque, TT; Jackson, KG; Kee, SA; Kolawole, EM; Pondicherry, N; Qayum, AA; Ryan, JJ; Spence, AJ; Straus, DB; Taruselli, MT | 1 |
| Haslinger, B; Kleemann, R; Kooistra, T; Toet, KH | 1 |
2 other study(ies) available for mevalonic acid and Primary Peritonitis
| Article | Year |
|---|---|
Fluvastatin enhances IL-33-mediated mast cell IL-6 and TNF production.
Topics: Animals; Cells, Cultured; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin E; Inflammation; Interleukin-33; Interleukin-6; Killer Cells, Natural; Macrophages; Mast Cells; Mevalonic Acid; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Peritonitis; Prenylation; Stem Cell Factor; Terpenes; Transcription Factor RelA; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2022 |
Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells.
Topics: Antineoplastic Agents; Cells, Cultured; Diterpenes; Epithelial Cells; Epithelium; Fibrinolysis; Gene Expression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Omentum; Peritoneal Dialysis; Peritoneum; Peritonitis; Plasminogen Activator Inhibitor 1; Simvastatin; Thromboplastin; Tumor Necrosis Factor-alpha | 2003 |